Microscopic Polyangiitis: all 65 studies
Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Ocular Manifestations of Granulomatosis With Polyangiitis.RecruitingNCT07664709
- Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis.Not yet recruitingNCT07451847Phase 4
- Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesRecruitingNCT07087912Phase 4
- Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)RecruitingNCT06983821Phase 3
- Special Drug Use-results Survey for Long-term Use（Avacopan）RecruitingNCT06758271
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)RecruitingNCT06350110Phase 1/2
- Clinical Transcriptomics in Systemic Vasculitis (CUTIS)RecruitingNCT03004326
- VCRC Tissue RepositoryRecruitingNCT02967068
- Vasculitis Pregnancy RegistryRecruitingNCT02593565
- Pediatric Vasculitis InitiativeRecruitingNCT02006134
- One-Time DNA Study for VasculitisRecruitingNCT01241305
- PR3-AAV Resilient Remission or PRRRTerminatedNCT05376319Phase 2Results posted
- Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.CompletedNCT03895801Phase 2Results posted
- Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPATerminatedNCT03712345Phase 2Results posted
- Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated VasculitisCompletedNCT02169219Phase 4Results posted
- A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic PolyangiitisCompletedNCT01750697Phase 2Results posted
- Rituximab Vasculitis Maintenance StudyCompletedNCT01697267Phase 3Results posted
- Belimumab in Remission of VASculitisCompletedNCT01663623Phase 3Results posted
- An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic PolyangiitisCompletedNCT01613599Results posted
- Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated VasculitisCompletedNCT00987389Phase 3Results posted
- Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic PolyangiitisCompletedNCT00104299Phase 2/3Results posted
- Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPAActive, not recruitingNCT06868290Phase 2
- Iptacopan in Patients With ANCA Associated VasculitisActive, not recruitingNCT06388941Phase 2
- Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)Active, not recruitingNCT06294236Phase 1
- An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular DiseasesActive, not recruitingNCT05732402Phase 1/2
- Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the OriginatorCompletedNCT05716334
- Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.CompletedNCT05703802
- Hydroxychloroquine in ANCA Vasculitis EvaluationTerminatedNCT04316494Phase 4
- PRagmatic Analysis of Vitamin D in ANCA-Associated VasculitisCompletedNCT04280601Not applicable
- Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic PolyangiitisCompletedNCT03920722Phase 3
- Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated VasculitisCompletedNCT03698071Not applicable
- Low Dose Naltrexone to Improve Physical Health in Patients With VasculitisCompletedNCT03482479Phase 2
- Journey of Patients With Vasculitis From First Symptom to DiagnosisCompletedNCT03410290
- Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase AntibodiesCompletedNCT03385668Phase 2
- The ANCA Vasculitis Questionnaire (AAV-PRO©)CompletedNCT02507024
- Impact of Vasculitis on Employment and IncomeCompletedNCT02476292
- Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated VasculitisTerminatedNCT02474888
- Comparison Between a Long Term and a Conventional Maintenance Treatment With RituximabCompletedNCT02433522Phase 3
- Low-dose Glucocorticoid Vasculitis Induction StudyStatus unknownNCT02198248Phase 4
- VCRC Patient Contact Registry Patient-Reported Data Validation StudyCompletedNCT02190942
- Educational Needs of Patients With Systemic VasculitisCompletedNCT02190929
- Vasculitis Illness Perception (VIP) StudyCompletedNCT02190916
- Reproductive Health in Men and Women With VasculitisCompletedNCT02176070
- Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary VasculitisStatus unknownNCT02126098
- A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic PolyangitisCompletedNCT02115997Phase 4
- Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)CompletedNCT01862068
- Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated VasculitisCompletedNCT01731561Phase 3
- PRO Development for ANCA Associated VasculitisStatus unknownNCT01729624
- BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel VasculitisWithdrawnNCT01598857Phase 2
- Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up StudyTerminatedNCT01586858
- Plasma Exchange for Renal VasculitisTerminatedNCT01408836Phase 2/3
- Alemtuzumab for ANCA Associated Refractory VasculitisStatus unknownNCT01405807Phase 4
- American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic VasculitisStatus unknownNCT01066208
- Anti-Cytokine Therapy for VasculitisCompletedNCT00753103Phase 2
- Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing VasculitidesStatus unknownNCT00751517Phase 2
- Efficacy Study of Two Treatments in the Remission of VasculitisCompletedNCT00748644Phase 3
- Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)CompletedNCT00647166Phase 3
- Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated VasculitidesCompletedNCT00430105Phase 2/3
- CellCept in p-ANCA VasculitisCompletedNCT00405860Phase 1
- CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis FactorsStatus unknownNCT00400075Phase 4
- Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic PolyangiitisCompletedNCT00315393
- Treatment of Necrotizing Vasculitides for Patients Older Than 65 YearsCompletedNCT00307671Phase 4
- IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic VasculitisTerminatedNCT00307645Phase 3
- RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing VasculitidesCompletedNCT00307593Not applicable
- Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)CompletedNCT00103792Phase 3